BAL PHARMA (India) Today

Equity ratings for BAL PHARMA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of November 2021 and ending today, the 3rd of December 2021. Click here to learn more.
BAL PHARMA cannot be verified against its exchange. It appears that BAL PHARMA is not available for investing at the moment. Please verify the symbol is currently traded on National Stock Exchange of India. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

BAL PHARMA Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. BAL PHARMA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BAL PHARMA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
BAL PHARMA is not yet fully synchronised with the market data
BAL PHARMA has some characteristics of a very speculative penny stock
BAL PHARMA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations
BAL PHARMA has accumulated about 43.25 M in cash with (4.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.04.
Legal NameBAL PHARMA
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of BAL PHARMA's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
BAL PHARMA (BALPHARMA) is traded on National Stock Exchange of India in India and employs 5 people. The company currently falls under 'Small-Cap' category with current market capitalization of 649.79 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BAL PHARMA's market, we take the total number of its shares issued and multiply it by BAL PHARMA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. BAL PHARMA operates under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 14.17 M outstanding shares. BAL PHARMA has accumulated about 43.25 M in cash with (4.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.04.
Check BAL PHARMA Probability Of Bankruptcy

BALPHARMA Stock Against Markets

Picking the right benchmark for BAL PHARMA stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in BAL PHARMA stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for BAL PHARMA is critical whether you are bullish or bearish towards BAL PHARMA at a given time.
BAL PHARMA cannot be verified against its exchange. It appears that BAL PHARMA is not available for investing at the moment. Please verify the symbol is currently traded on National Stock Exchange of India. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BAL PHARMA stock to make a market-neutral strategy. Peer analysis of BAL PHARMA could also be used in its relative valuation, which is a method of valuing BAL PHARMA by comparing valuation metrics with similar companies.
Check out Trending Equities. Note that the BAL PHARMA information on this page should be used as a complementary analysis to other BAL PHARMA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Search module to search for activelly traded equities including funds and ETFs from over 30 global markets.

Other Tools for BALPHARMA Stock

When running BAL PHARMA price analysis, check to measure BAL PHARMA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BAL PHARMA is operating at the current time. Most of BAL PHARMA's value examination focuses on studying past and present price action to predict the probability of BAL PHARMA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BAL PHARMA's price. Additionally, you may evaluate how the addition of BAL PHARMA to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go